Cite
HARVARD Citation
Nishiyama, A. et al. (2020). MET amplification results in heterogeneous responses to osimertinib in EGFR‐mutant lung cancer treated with erlotinib. Cancer science. 111 (10), pp. 3813-3823. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nishiyama, A. et al. (2020). MET amplification results in heterogeneous responses to osimertinib in EGFR‐mutant lung cancer treated with erlotinib. Cancer science. 111 (10), pp. 3813-3823. [Online].